宫颈人乳头瘤病毒感染的治疗进展  

Progress in the treatment of cervical human papillomavirus infection

作　　者：刘佳兰 董建新 郝洋 陈燕 LIU Jialan;DONG Jianxin;HAO Yang;CHEN Yan(Department of Obstetrics and Gynecology,North China University of Science and Technology Affiliated Hospital,Tangshan,Hebei,063000,China)

机构地区：[1]华北理工大学附属医院妇产科,河北唐山063000

出　　处：《当代医学》2021年第26期191-194,共4页Contemporary Medicine

基　　金：河北省卫生厅医学科学研究重点科技研究计划(20180780)。

摘　　要：人类乳头瘤病毒导致约5%的人类癌症,高危型人乳头瘤病毒(HR-HPV)持续感染是引发子宫颈鳞状上皮内病变、宫颈癌的主要因素。近年来,HPV感染率持续升高且呈年轻化趋势,及早发现HPV感染,逆转HPV感染持续状态具有重要意义。本文讨论了宫颈HPV感染的西药、中药、物理、手术治疗以及预防性疫苗和治疗性疫苗的进展,并简述其用法及操作要点,为临床预防和治疗提供参考。Human papillomaviruses cause around 5%of all human cancers,persistent infection of high-risk human papillomavirus(HR-HPV)is the main cause of cervical squamous intraepithelial lesion and cervical cancer.In recent years,the infection rate of HPV continues to increase.It is of great significance to detect HPV infection early and reverse the persistent state of HPV infection.This article discusses the progress of Western medi-cine therapy,Traditional Chinese medicine therapy,physical therapy or surgery,and prophylactic vaccines and therapeutic vaccines of cervical HPV infection,and briefly describes its usage and operation points to provide reference for clinical prevention and treatment.

关 键 词：宫颈 人乳头瘤病毒 治疗 鳞状上皮内病变 

分 类 号：R737.33[医药卫生—肿瘤]